Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage. [electronic resource]
Producer: 20090605Description: 264-73 p. digitalISSN:- 1769-714X
- Animals
- CCR5 Receptor Antagonists
- CD4-Positive T-Lymphocytes -- immunology
- Chagas Cardiomyopathy -- drug therapy
- Chagas Disease -- drug therapy
- Chemokine CCL5 -- pharmacology
- Connexin 43 -- analysis
- Female
- Heart -- parasitology
- Immunologic Factors -- pharmacology
- Interleukin-10 -- biosynthesis
- Interleukin-13 -- biosynthesis
- Mice
- Mice, Inbred C3H
- Myocardium -- chemistry
- Receptors, CCR1 -- antagonists & inhibitors
- Trypanosoma cruzi -- physiology
- Tumor Necrosis Factor-alpha -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.